personalized medicine
Phosphorus Wins Conditional New York State Approval for GeneCompass Consumer Test
The firm's health screening sequencing assay, which retails at $249 and covers a panel of over 400 genes, will now be available to consumers in all 50 states.
Helix, Medical University of South Carolina Partner for Population Genomics Program
The effort plans to enroll 100,000 patients and return genetic findings in order to drive personalized and proactive care and to grow a clinico-genomic database.
Vibrent Health, University of Maryland Medicine Partner for Population Health Initiative
The study aims to enroll up to 250,000 volunteers across Maryland and will create a digital platform to study how genes and other factors affect health.
Nature Papers Examine Factors Affecting Mutation Detection, Map of Development, Sequencer Performance
In Nature this week: factors influencing clinical cancer mutation detection, overview of the Human Developmental Cell Atlas, and more.
Recuro Health Acquires 'Health Intelligence' Firm MyLifeIQ
Recuro hopes to integrate MyLifeIQ's epigenetics-based "health intelligence platform" to deliver personalized health recommendations based on DNA tests and wearable sensor data.